These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease. Urata S, Yun N, Pasquato A, Paessler S, Kunz S, de la Torre JC. J Virol; 2011 Jan; 85(2):795-803. PubMed ID: 21068251 [Abstract] [Full Text] [Related]
14. Identification of a clinical compound losmapimod that blocks Lassa virus entry. Zhang X, Yan F, Tang K, Chen Q, Guo J, Zhu W, He S, Banadyga L, Qiu X, Guo Y. Antiviral Res; 2019 Jul 03; 167():68-77. PubMed ID: 30953674 [Abstract] [Full Text] [Related]
15. Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library. Lan X, Zhang Y, Jia X, Dong S, Liu Y, Zhang M, Guo J, Cao J, Guo Y, Xiao G, Wang W. Antiviral Res; 2022 Jan 03; 197():105230. PubMed ID: 34965446 [Abstract] [Full Text] [Related]
16. SAR studies of 4-acyl-1,6-dialkylpiperazin-2-one arenavirus cell entry inhibitors. Plewe MB, Whitby LR, Naik S, Brown ER, Sokolova NV, Gantla VR, York J, Nunberg JH, Zhang L, Kalveram B, Freiberg AN, Boger DL, Henkel G, McCormack K. Bioorg Med Chem Lett; 2019 Nov 15; 29(22):126620. PubMed ID: 31537423 [Abstract] [Full Text] [Related]
20. A specific interaction of small molecule entry inhibitors with the envelope glycoprotein complex of the Junín hemorrhagic fever arenavirus. Thomas CJ, Casquilho-Gray HE, York J, DeCamp DL, Dai D, Petrilli EB, Boger DL, Slayden RA, Amberg SM, Sprang SR, Nunberg JH. J Biol Chem; 2011 Feb 25; 286(8):6192-200. PubMed ID: 21159779 [Abstract] [Full Text] [Related] Page: [Next] [New Search]